ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.73
+0.08 (+2.82%)
As of Sep 22, 10:03 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +771.1% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.73
Current
$2.73
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
703.3%
Low target
Base Case
$23.78
+771.1%
Avg target
Bull Case
$37.21
+1,263.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.00
-31.8% from high
52-Week Low
$2.10
+30.3% from low
Target vs 52W High
$23.78
+494.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%